Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis
Masahiro Makinoya(Tottori University), Yoshiyuki Fujiwara(Tottori University)
Cited by 11
Related Papers
Increased regulatory B cells are involved in immune evasion in patients with gastric cancer
|Scientific Reports|2019|123
Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
|Anticancer Research|2018|53
AMIGO2 as a novel indicator of liver metastasis in patients with colorectal cancer
|Oncology Letters|2021|25
Prognostic Significance of TYRO3 Receptor Tyrosine Kinase Expression in Gastric Cancer
|Anticancer Research|2020|4
エクソソーム由来のmiR-493はMAD2L1の抑制を介して腹膜転移を有する胃癌患者へのパクリタキセルの腹腔内投与療法への抵抗性を惹起する
|Institutional Repositories DataBase (IRDB)|2024|0